GlassScriptPhysician profile
Steven Keith Bowen
NPI 1508800988
$1,586.19
in general payments reported to CMS, 2019-2025
23 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $145 · 2021: $189 · 2022: $311 · 2023: $460 · 2024: $166 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $290.18 | 2021-2025 | Tenoglide, Integra, Integra Dermal Regeneration Template |
| Ibsa Pharma INC. | $251.04 | 2020-2022 | |
| Kerecis Limited | $125.05 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $122.53 | 2019-2025 | Stravix, Grafix Pl, Oasis |
| Medtronic, INC. | $117.87 | 2022-2023 | Intellis Adaptivestim |
| Horizon Therapeutics Plc | $114.94 | 2019-2021 | |
| Grt US Holding, INC. | $80.31 | 2020-2022 | |
| Nevro Corp. | $68.81 | 2023-2024 | Senza |
| Abbvie INC. | $46.70 | 2024-2025 | |
| Melinta Therapeutics, LLC | $41.57 | 2019 | |
| Gramercy Extremity Orthopedics LLC | $36.90 | 2025 | |
| Djo, LLC | $36.81 | 2019-2020 | |
| Zyla Life Sciences, INC. | $33.67 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $31.20 | 2023-2024 | Nuzyra |
| Davol INC. | $30.18 | 2025 | Arista |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $27.47 | 2024 | |
| Ermi LLC | $24.82 | 2024 | |
| Baxter Healthcare | $23.93 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.87 | 2023 | Jublia |
| Bioventus LLC | $17.34 | 2024 | Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $16.39 | 2023 | Phantom Intramedullary Nail |
| Pfizer INC. | $14.69 | 2019 | |
| Forte Bio-Pharma LLC | $9.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.